{ "company_number": "09526225", "name": "Nuvision Biotherapies Limited", "url": "/company/09526225", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2015-04-07", "dissolved_on": null, "sic_codes": [ { "code": "21200", "description": "Manufacture of pharmaceutical preparations", "section": "C", "section_name": "Manufacturing", "url": "/sic/21200" } ], "registered_address": { "id": 2101601, "url": "/address/2101601", "line1": "MEDICITY, D6 BUILDING", "line2": "THANE ROAD", "post_town": "NOTTINGHAM", "county": "", "country": "ENGLAND", "postcode": "NG90 6BH" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/09526225", "previous_names": [ { "name": "NU Vision Biotherapies Limited", "ceased_on": "2015-08-08" } ], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2027-03-31", "last_made_up": "2025-06-30", "category": "TOTAL EXEMPTION FULL", "filings": [ { "url": "/company/09526225/accounts/2025-06-30", "pdf_url": "/company/09526225/accounts/2025-06-30.pdf", "made_up_date": "2025-06-30", "period_start": "2025-06-30", "period_end": "2025-06-30", "entity_name": "Nuvision Biotherapies Limited", "dormant": false, "average_employees": "21.00", "tangible_fixed_assets": "54403.00", "debtors": "236260.00", "cash_bank_in_hand": "928803.00", "current_assets": "1384160.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "1028895.00", "total_assets_less_current_liabilities": "1083298.00", "net_assets_liabilities": "1078113.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "217.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-March2026.zip" }, { "url": "/company/09526225/accounts/2024-06-30", "pdf_url": "/company/09526225/accounts/2024-06-30.pdf", "made_up_date": "2024-06-30", "period_start": "2024-06-30", "period_end": "2024-06-30", "entity_name": "Nuvision Biotherapies Limited", "dormant": false, "average_employees": "18.00", "tangible_fixed_assets": "40460.00", "debtors": "145453.00", "cash_bank_in_hand": "44293.00", "current_assets": "390510.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-2117.00", "total_assets_less_current_liabilities": "38343.00", "net_assets_liabilities": "-177047.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "167.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2025.zip" }, { "url": "/company/09526225/accounts/2023-03-31", "pdf_url": "/company/09526225/accounts/2023-03-31.pdf", "made_up_date": "2023-03-31", "period_start": "2023-03-31", "period_end": "2023-03-31", "entity_name": "NuVision Biotherapies Limited", "dormant": false, "average_employees": "14.00", "tangible_fixed_assets": "59909.00", "debtors": "282700.00", "cash_bank_in_hand": "645677.00", "current_assets": "1071100.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "909928.00", "total_assets_less_current_liabilities": "969837.00", "net_assets_liabilities": "947337.00", "called_up_share_capital": "160.00", "profit_loss_account_reserve": "-5400093.00", "shareholder_funds": "160.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-May2023.zip" }, { "url": "/company/09526225/accounts/2022-03-31", "pdf_url": "/company/09526225/accounts/2022-03-31.pdf", "made_up_date": "2022-03-31", "period_start": "2022-03-31", "period_end": "2022-03-31", "entity_name": "NuVision Biotherapies Limited", "dormant": false, "average_employees": "13.00", "tangible_fixed_assets": "69824.00", "debtors": "313595.00", "cash_bank_in_hand": "673293.00", "current_assets": "1136619.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "732297.00", "total_assets_less_current_liabilities": "802121.00", "net_assets_liabilities": "769621.00", "called_up_share_capital": "143.00", "profit_loss_account_reserve": "-4481585.00", "shareholder_funds": "143.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-April2022.zip" }, { "url": "/company/09526225/accounts/2021-03-31", "pdf_url": "/company/09526225/accounts/2021-03-31.pdf", "made_up_date": "2021-03-31", "period_start": "2021-03-31", "period_end": "2021-03-31", "entity_name": "NuVision Biotherapies Limited", "dormant": false, "average_employees": "21.00", "tangible_fixed_assets": "85109.00", "debtors": "234671.00", "cash_bank_in_hand": "1023660.00", "current_assets": "1349664.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "1112530.00", "total_assets_less_current_liabilities": "1197639.00", "net_assets_liabilities": "183584.00", "called_up_share_capital": "118.00", "profit_loss_account_reserve": "-3273778.00", "shareholder_funds": "118.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-July2021.zip" }, { "url": "/company/09526225/accounts/2020-03-31", "pdf_url": "/company/09526225/accounts/2020-03-31.pdf", "made_up_date": "2020-03-31", "period_start": "2020-03-31", "period_end": "2020-03-31", "entity_name": "NuVision Biotherapies Limited", "dormant": false, "average_employees": "16.00", "tangible_fixed_assets": "95447.00", "debtors": "212489.00", "cash_bank_in_hand": "165566.00", "current_assets": "446071.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "194562.00", "total_assets_less_current_liabilities": "290009.00", "net_assets_liabilities": "290009.00", "called_up_share_capital": "108.00", "profit_loss_account_reserve": "-2255090.00", "shareholder_funds": "108.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2020.zip" }, { "url": "/company/09526225/accounts/2019-03-31", "pdf_url": "/company/09526225/accounts/2019-03-31.pdf", "made_up_date": "2019-03-31", "period_start": "2019-03-31", "period_end": "2019-03-31", "entity_name": "NuVision Biotherapies Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "62744.00", "debtors": "147643.00", "cash_bank_in_hand": "46180.00", "current_assets": "228108.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "84255.00", "total_assets_less_current_liabilities": "146999.00", "net_assets_liabilities": "146999.00", "called_up_share_capital": "95.00", "profit_loss_account_reserve": "-1261495.00", "shareholder_funds": "95.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2019.zip" }, { "url": "/company/09526225/accounts/2018-03-31", "pdf_url": "/company/09526225/accounts/2018-03-31.pdf", "made_up_date": "2018-03-31", "period_start": "2018-03-31", "period_end": "2018-03-31", "entity_name": "NuVision Biotherapies Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "57504.00", "debtors": "150785.00", "cash_bank_in_hand": "276550.00", "current_assets": "460353.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "280802.00", "total_assets_less_current_liabilities": "338306.00", "net_assets_liabilities": "338306.00", "called_up_share_capital": "93.00", "profit_loss_account_reserve": "-755326.00", "shareholder_funds": "93.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-July2018.zip" }, { "url": "/company/09526225/accounts/2017-03-31", "pdf_url": "/company/09526225/accounts/2017-03-31.pdf", "made_up_date": "2017-03-31", "period_start": "2016-04-01", "period_end": "2017-03-31", "entity_name": "Nuvision Biotherapies Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "52808.00", "debtors": "241162.00", "cash_bank_in_hand": "9701.00", "current_assets": null, "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": null, "total_assets_less_current_liabilities": null, "net_assets_liabilities": null, "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "88.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "-325972.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-July2017.zip" }, { "url": "/company/09526225/accounts/2016-03-31", "pdf_url": "/company/09526225/accounts/2016-03-31.pdf", "made_up_date": "2016-03-31", "period_start": "2016-03-31", "period_end": "2016-03-31", "entity_name": "NU Vision Biotherapies Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "59170.00", "debtors": "108544.00", "cash_bank_in_hand": "120067.00", "current_assets": "243572.00", "creditors_due_within_one_year": "96661.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "146911.00", "total_assets_less_current_liabilities": "206081.00", "net_assets_liabilities": null, "called_up_share_capital": "86.00", "profit_loss_account_reserve": "-172919.00", "shareholder_funds": "206081.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2016.zip" } ], "pdf_only_filings": [], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/09526225/filing-history" }, "confirmation_statement": { "next_due": "2027-02-25", "last_made_up": "2026-02-11" }, "officers": [], "psc": [ { "name": "Mercia Growth Nominees 5 Limited", "kind": "corporate-entity-person-with-significant-control", "person_url": null, "controlling_company_url": "/company/09959377", "natures_of_control": [ "voting-rights-25-to-50-percent" ], "notified_on": "2016-04-06", "ceased_on": null, "nationality": "", "country_of_residence": "", "source": "snapshot" }, { "name": "Ugf Nominees Limited", "kind": "corporate-entity-person-with-significant-control", "person_url": null, "controlling_company_url": "/company/09775446", "natures_of_control": [ "voting-rights-25-to-50-percent" ], "notified_on": "2016-04-06", "ceased_on": null, "nationality": "", "country_of_residence": "", "source": "snapshot" }, { "name": "Mercia Growth Nominees 4 Limited", "kind": "corporate-entity-person-with-significant-control", "person_url": null, "controlling_company_url": "/company/09461920", "natures_of_control": [ "voting-rights-25-to-50-percent" ], "notified_on": "2016-04-06", "ceased_on": null, "nationality": "", "country_of_residence": "", "source": "snapshot" }, { "name": "The University Of Nottingham", "kind": "corporate-entity-person-with-significant-control", "person_url": null, "controlling_company_url": "/company/RC000664", "natures_of_control": [ "ownership-of-shares-25-to-50-percent" ], "notified_on": "2016-04-06", "ceased_on": null, "nationality": "", "country_of_residence": "", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-08-01", "retrieved_at": "2026-08-14T22:50:00.959197+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }